Zoono (ASX:ZNO) share price slumps 16% on quarterly update

Despite some positive advancements, shareholders continued the selling pressure on Zoono shares today.

| More on:
A woman wearing glasses peers closely at something, ready to spray antimicrobial treatment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price slipped into the red in today's session. The dip arrives as Zoono announced its progress for the quarter.

Let's comb over the company's results and highlights in finer detail.

Quick refresher on Zoono

Zoono is a biotechnology company that specialises in environmentally-friendly antimicrobial products.

Its mission statement centres on providing non-toxic and sustainable germ protection to individuals across the globe.

Zoono has a market capitalisation of $108 million.

Zoono's quarterly results

The company has realised $28.8 million in cash receipts for the full year. This includes unaudited sales revenue of $6.6 million for the quarter.

Zoono also announced a suite of new sales and distribution agreements that are now in place. These include sales and distribution agreements in France, Russia, China and India.

For instance, Zoono is now selling to "several French multinational customers," and it has signed three new distribution agreements in China.

Furthermore, a new distributor in India placed a large 100,000-litre order, and "sales have been particularly strong in the public sector" in Russia.

Zoono exited the quarter with $7.4 million in cash and receivables. All positive signs for the Zoono share price.

Additional takeouts driving the Zoono share price

In addition to these agreements, Zoono announced a selection of "new business opportunities" in the report.

To illustrate, Zoono described advancements in "mould remediation" with a partner in South Africa. This activity aims to "prevent black mould growing on cardboard packaging".

Moreover, Zoono UK has started a strategic partnership with a third party in order to develop "a unique delivery system" for its Zoono Z-71 microbe shield.

The company is testing this system using "existing air conditioning infrastructure" in large buildings.

The proprietary process, which is owned by the third party, converts Zoono's solution into a gas.

As per the company, the gas "is then pumped throughout the building" via the air con. Because the "gasified Zoono is heavier than air, it settles on (and treats) the surface" it lands on.

Again on the the Z-71 shield, it displayed a "99.99% efficacy against [preventing] Coronavirus MHV-3 after 30 days" in trials conducted on the product in Brazil.

Despite these advancements, shareholders continued the selling pressure on Zoono shares today.

Zoono shares closed the day at 66 cents apiece, a 15.92% drop into the red from the market open.

Zoono share price snapshot

The Zoono share price has posted a year-to-date loss of nearly 50%, extending the previous 12 month's loss of 70%.

Both of these returns have lagged the S&P/ASX 200 Index (ASX: XJO) return of ~23% over the past year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Record Highs

Big ASX 200 news! Market hits 8,700-point record high

It's a historic day for the ASX.

Read more »

Miner with thumbs up at mine
Broker Notes

Up 55% this year, does Macquarie rate Gold Road Resources shares a buy, hold or sell?

Does this strong performing gold miner have more room to run?

Read more »

Two happy woman on a couch looking at a tablet.
Opinions

Why I'm excited to see the results of these ASX 200 shares

These stocks could reveal very interesting insights.

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Morgans names 3 ASX stocks to buy

The broker is feeling very positive on the investment opportunities here.

Read more »